1-hydroxymethylmidazolam has been researched along with Hepatic Failure in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bastien, O; Bolon, M; Boulieu, R; Flamens, C; Lehot, JJ | 1 |
de Hoog, M; de Wildt, SN; van den Anker, JN; van der Giesen, E; Vinks, AA | 1 |
1 trial(s) available for 1-hydroxymethylmidazolam and Hepatic Failure
Article | Year |
---|---|
[Use of midazolam in postoperative sedation of patients with multiple organ failure treated with hemodiafiltration. Clinical study and pharmacokinetics].
Topics: Adjuvants, Anesthesia; Aged; Biotransformation; Chromatography, Liquid; Female; Half-Life; Hemofiltration; Humans; Liver Failure; Male; Midazolam; Middle Aged; Multiple Organ Failure; Renal Insufficiency | 2002 |
1 other study(ies) available for 1-hydroxymethylmidazolam and Hepatic Failure
Article | Year |
---|---|
Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
Topics: Adolescent; Aryl Hydrocarbon Hydroxylases; Bayes Theorem; Child; Child, Preschool; Conscious Sedation; Critical Care; Cytochrome P-450 CYP3A; Female; Humans; Hypnotics and Sedatives; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Liver Failure; Male; Mathematical Computing; Metabolic Clearance Rate; Midazolam; Oxidoreductases, N-Demethylating; Renal Insufficiency | 2003 |